Anapol Schwartz - Attorneys at Law
Ethex Morphine Recall

The Dextroamphetamine Sulfate Tablets Recall

Dextroamphetamine Sulfate Tablets are used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. When the drug is used to treat ADHD symptoms, it is most often used for children aged 3 - 16 as part of a total treatment program that includes psychological, education and social components.

While the drug is very effective, there are some significant risks associated with the use of amphetamines. Amphetamines can be highly addictive and, therefore, have a high potential for abuse.

Overdose Levels

According to the Ethex Corporation, the manufacturer of Dextroamphetamine Sulfate Tablets, the level at which an individual overdoses on this drug is highly individualized. Some patients will experience overdose symptoms at levels as low as 2 mg while other patients may be tolerate much higher levels.

Accordingly, it is very important that a patient take the dose prescribed by a doctor and be carefully monitored while on the drug since even a small overdose of Dextroamphetamine Sulfate can be dangerous.

Contact Our Ethex Morphine Recall Lawyers Today »

Symptoms of An Overdose

Patients who receive too much of Dextroamphetamine Sulfate may begin to have tremors, restlessness, rapid respiration, confusion, hallucinations, and panic attacks, for example. Cardiovascular symptoms may include arrhythmias, hypertension or hypotension. Gastrointestinal symptoms may include nausea, vomiting and diarrhea. Fatal poisonings can occur and it is important for any patient who experiences these symptoms to seek emergency medical attention and to call Poison Control immediately.

The Recall

Given the importance of taking a safe, accurate and medically prescribed dose of Dextroamphetamine Sulfate Tablets, the Ethex Corporation issued a recall of certain Dextroamphetamine Sulfate Tablets because some of the pills in certain batches appeared to be double the appropriate thickness and could, therefore, contain up to two times the advertised level of the drug in each tablet.

In November 2008, Ethex recalled 10 mg tablets of Dextroamphetamine Sulfate from five specific lots that had expiration dates between June 2009 and May 2011. The tablets were orange, round, flat faced tablets with a beveled edge. “ETHEX” and “312” were debossed on one side and the other side was double scored.

Do You Have an Ethex Morphine Recall Case? »

Ethex, with the knowledge of the FDA, requested that distributors such as hospitals and pharmacies return Dextroamphetamine Sulfate Tablets from the recalled lots. However, some of the medication had likely already been distributed to consumers. Consumers who had any questions about the medication were urged to call the company, their pharmacist or physician. Consumers were also advised to seek immediate medical care in the event that they experienced adverse reactions to the drug.

Amphetamine overdoses are serious and can be life threatening. Consumers put their trust in drug manufacturers to produce tablets in the advertised dosages so that pharmacists can accurately fill physicians’ prescriptions. When that doesn’t happen, consumers are put at risk of serious side effects.

 

Please fill out the form below to see if you have a Ethex morphine recall case.


PERSONAL INFORMATION
First Name:
Last Name:
E-mail Address:
Phone: -
Address:
City:
State:
Zipcode:

INCIDENT INFORMATION
Dates drug was taken from:  
to:       
Dosage taken:
Please describe any side effects:
Other comments/questions: